About
TracInnovations
TracInnovations is a Danish company established in 2015 focused on improving image-based diagnosis for better health outcomes. TracInnovations has developed the Tracoline system, an MRI Markerless Motion Tracker and Monitoring System that unnoticed records patient’s head movements during brain scans.
Innovative medical solutions
Through dedication and hard work, we are driven to bring innovative solutions to the medical field, continually striving to improve our offering to keep our customers at the forefront of technological advancement.
Vision
TracInnovations makes it possible to scan and diagnose patients who move during a neurology MRI scan.
Our passion is to make it possible to avoid sedation during pediatric MRI scans, increase patient comfort and improve the workflow
Nicklas Hall Jarnel
CEONicklas is a serial entrepreneur and an experienced business developer.
He is the co-founder of Norlase ApS and GLStandard and is an expert in strategy and fundraising.
Stefan Glimberg
CTOStefan has a PhD in advanced mathematics and computer science.
He is an expert in computer vision, and has worked with TracInnovations’ for 5+ years.
Thomas Gaass
CSOThomas holds a PhD in Physics.
His expertise in medical imaging physics, MRI application development, and clinical science have consistently driven innovation and progress.
Michelle Stock
Director of BD & Sales NAMichelle is an experienced business developer with 15+ years in high-tech industries.
She has a PhD in Optics, and has co-founded Arbor Photonics.
Key
Collaborators
Key collaborators and investors are critical to the success of any business venture. That is why we prioritize them and thank them for their support.
We aim at establishing strong relationships based on trust, transparency, communication, and mutual respect. In short, we believe that effective collaboration with strategic partners remains one of the most important ingredients for long-term business success.
Our partners and investors
Working in partnership with leading organizations, we are committed to furthering their research and development to continue the journey of innovation and discovery.